What we're reading, February 1, 2016: some medical researchers disagree with sharing raw data used in their research; the medical community is torn on whether or not the annual checkup is worthwhile; and Donald Trump vows to extend healthcare coverage to the lower class.
While medical researchers agree in theory with Vice President Joe Biden’s cancer moonshot proposal, the idea of sharing raw data used in research has created dissension among the community, according to POLITICO. The trouble started when New England Journal of Medicine ran an op-ed pointing out that while data sharing was good, it could not be done by so-called “data parasites,” who would misuse work that took researchers years to assemble.
Physicians remain mixed on whether or not the annual checkup is a worthwhile endeavor. The annual checkup was once an unquestioned practice, but now it is being debated with some medical societies recommending against it for healthy adults. USA Today has highlighted some pros and cons of having routine checkups that may help consumers decide whether or not having one is right for them. Included in the lists is the fact that routine checkups provide an opportunity to fit in proven screening and prevention practices (pro) and that routine checkups waste time and money and can actually harm patients sometimes (cons).
Donald Trump continues to set himself apart from his Republican opponents. Although he remains vague on the details, the GOP frontrunner pledged to extend healthcare coverage to the lower class, reported The Hill. However, he denied that he was calling for a single-payer system, as rival Ted Cruz has said. Trump acknowledged that he might lose the election based on his vow.
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More